Charles Cape
Vascular Neurology · Germantown, TNNPI 1063483923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $630 and has fallen 53.5% since, to $293 in 2025.
Across 98 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$249
- Vanda Pharmaceuticals Inc.$209
- Argenx US, Inc.$198
- Otsuka America Pharmaceutical, Inc.$125
- Alnylam Pharmaceuticals Inc.$109
- Genentech USA, Inc.$105
- plus $914 from 21 others
What the payments were for
- Food & beverage$1,909100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $249 |
| Vanda Pharmaceuticals Inc. | 4 | $209 |
| Argenx US, Inc. | 11 | $198 |
| Otsuka America Pharmaceutical, Inc. | 6 | $125 |
| Alnylam Pharmaceuticals Inc. | 6 | $109 |
| Genentech USA, Inc. | 6 | $105 |
| Novartis | 5 | $96 |
| Lilly USA, LLC | 6 | $89 |
| Eisai Inc. | 5 | $89 |
| Biogen | 4 | $73 |
| EMD Serono, Inc. | 4 | $72 |
| Sunovion Pharmaceuticals Inc. | 4 | $67 |
| CSL Behring | 4 | $63 |
| UCB, Inc. | 2 | $62 |
| Acorda Therapeutics, Inc | 2 | $48 |
| Tanabe Pharma America, Inc. | 3 | $46 |
| Lundbeck LLC | 2 | $33 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Neurelis, Inc. | 1 | $25 |
| TG Therapeutics, Inc. | 1 | $21 |
| AstraZeneca | 1 | $18 |
| Avion Pharmaceuticals | 1 | $17 |
| Sobi, Inc | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Grifols USA, LLC | 1 | $12 |
| Corium, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ponvory$167
How this compares
Too few vascular neurology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Other vascular neurology in Germantown
- Violiza AcostaMemphis$105K
- Deborah KerriganNashville$7K
- Himanshu PatelNashville$6K
- David ParrellaNashville$5K
- David CurfmanNashville$3K
- Kaushik ParshaMemphis$786
- Cory RiceChattanooga$732
- Phaniraj IyengarNashville$618
- Beth Anne CavanaughMemphis$433
- Nirav ShahMemphis$356
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.